Loading...
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials
BACKGROUND: We sought to develop a prognostic scoring system to aid in patient selection for immune checkpoint inhibitor (ICI) phase 1 clinical trials. METHODS: Clinical data from patients treated in phase 1 ICI clinical trials at MD Anderson (MDA) Center were analysed. Seventeen clinical factors we...
Na minha lista:
Udgivet i: | Br J Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Nature Publishing Group
2018
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5886120/ https://ncbi.nlm.nih.gov/pubmed/29462132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.480 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|